DRKS00011489已完成不适用
RAD327 Lu-177 Dosimetry with SPECT/CT - RAD327 COMPARE PRRT
niversitätsklinikum Magdeburg0 个研究点目标入组 6 人开始时间: 2017年7月19日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Indication for Lutetium-177-DOTATATE therapy
- •- by minimum two successfully performed therapy cycles
- •- age > 18 years
- •- normal renal function
- •- no contraindication for the second examinations (e.g. claustrophobia, poor general condition)
排除标准
- •Missing compliance to the additional examinations
研究者
相似试验
招募中
早期 1 期
177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate CancerNCT05603559Peking Union Medical College Hospital30
进行中（未招募）
不适用
Receptorial radiotherapy with 177Lu DOTATATE in somatostatine receptors positive tumours, a phase II study.cancer patientsMedDRA version: 14.1Level: HLGTClassification code 10014713Term: Endocrine neoplasms malignant and unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-002891-18-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI
招募中
4 期
Measurement of safety limit of radionuclide therapy in treatment of patients with prostate cancerCTRI/2016/06/006998All India Institute of Medical Sciences50
进行中（未招募）
不适用
Receptorial radiotherapy with 177Lu-DOTA-Tyr3-Octreotate as Maintaining Therapy in Extended Small Cell Lung Cancer (SCLC) after a first standard chemotherapy line - IRST162.02oncological patientsMedDRA version: 12.1Level: LLTClassification code 10026532Term: Malignant neoplasm of thoraxEUCTR2010-018333-21-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI
招募中
1 期
Therapy with radiopharmaceutical 177Lu-DOTATOC (177Lu-edotreotide or 177Lu-octreotide) in patients with diagnosis of somatostatin receptor positive tumor: a multicenter, prospective phase 2 studyPatients must have histologically or cytologically confirmation of neuroendocrine tumors or any other tumor histotype documented as sst-positiveMedDRA version: 20.0Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2023-000086-14-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS268